Developmental Research Program for Translational Myeloma Science
Official title: Developmental Research Program
Funded at Mayo Clinic Arizona · NIH-11421176 · Data updated 2026-11-12
A Mayo Clinic program funds early, promising myeloma research with translational potential to move discoveries toward patient care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Arizona NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 1, 2015 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $117,195 |
| NIH project number | 2P50CA186781-11 |
| Project ID | NIH-11421176 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults diagnosed with or at risk for myeloma who could benefit from upcoming translational findings and future clinical applications.
✕Less likely to help
Patients seeking immediate, established treatments rather than novel translational work may not directly benefit from this stage.
What this research studies
The Developmental Research Program in Mayo Clinic's SPORE for Multiple Myeloma supports fresh, scientifically sound ideas that can bridge lab findings to real treatments for myeloma. It encourages innovative methods and approaches not previously used in myeloma studies, with a goal of increasing translational activity among scientists and clinicians. The program provides structured funding and oversight to select and monitor 3–4 one-year projects, with a possible second year for strong progress. The long-term aim is to translate discoveries into reduced incidence and mortality from myeloma. Researchers may apply for up to $140,000 annually, combining SPORE funds and Mayo Clinic matching funds.
Why it matters
Potential benefit: If successful, the program could accelerate new translational myeloma therapies and strategies that improve patient outcomes.
How similar studies have gone: Similar translational development programs in cancer research have yielded new targets and early-phase approaches; this program emphasizes development that could lead to clinical impact.
Where this research is happening
-
Mayo Clinic Arizona
Scottsdale, United States Active
Researchers
- Principal investigator: Chesi, Marta — Mayo Clinic Arizona
- Study coordinator: Chesi, Marta
Related research
Other NIH-funded projects on the same topics.
-
Predicting Pain Recovery with a Multimodal AI using Harmonized Health Records
Aging patients with headaches will be helped by a new AI tool that uses medical records and brain images from Mayo Clinic and VA to predict who might have persistent pain.
-
Understanding immune signals in ALS to guide future therapies
A Mayo Clinic team will study how the immune system sees proteins in the brain of people with ALS and related conditions, to find clues for better treatments.
-
Determinants of Pathogenic Anti-PF4 Antibody–Mediated Platelet Activation
This project looks at why certain anti-PF4 antibodies in people cause harmful blood clots and how to better diagnose and treat those cases.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
EHMT1 Variants and Kleefstra Syndrome: How Structure Shapes Neurodevelopmental Risks
A small NIH grant will explore how genetic changes in EHMT1 affect brain development in Kleefstra Syndrome using computer models and analysis of protein structure.
-
Targeting epigenomic regulators to assault pancreatic cancer replication stress
This research tests a new way to treat pancreatic cancer by blocking key epigenetic regulators during DNA replication to make cancer cells less able to cope with replication stress.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.